V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002605 | 10001711 | 1.6 | 61.4 | Palliative (P) | 2018-08-28 | 2018-09-12 | PEMBROLIZUMAB | 02 | Y | 10439772 | PEMBROLIZUMAB |
| 10002606 | 10001712 | null | 0 | Neo-adjuvant (N) | 2013-07-05 | 2013-07-10 | ECX | N | null | 10439830 | ECX |
| 10002607 | 10001713 | null | 96.2 | Curative (C) | 2015-05-24 | 2015-06-17 | CVP R | 02 | N | 10439849 | CVP R |
| 10002608 | 10001713 | 1.72 | 70.5 | Disease modification (D) | 2015-09-30 | 2015-10-04 | Cisplatin + Pemetrexed | 02 | N | 10439849 | CISPLATIN + PEMETREXED |
| 10002609 | 10001714 | 1.69 | 63.8 | null | 2018-03-05 | 2018-03-06 | GO2 TRIAL | 01 | N | 10439881 | TRIAL |
| 10002610 | 10001715 | 1.63 | 72 | Palliative (P) | 2014-01-20 | 2014-01-28 | EOX | N | N | 10439898 | EOX |
| 10002611 | 10001716 | 1.6 | 91 | Curative (C) | 2017-11-01 | 2017-11-01 | Hydroxycarbamide | 02 | N | 10439905 | HYDROXYCARBAMIDE |
| 10002612 | 10001717 | 1.7 | 76.5 | Disease modification (D) | 2017-06-27 | 2017-07-09 | Rituximab | null | N | 10439983 | RITUXIMAB |
| 10002613 | 10001718 | 1.55 | 83.2 | Palliative (P) | 2018-03-25 | 2018-04-16 | Cisplatin + Pemetrexed | 2 | N | 10439992 | CISPLATIN + PEMETREXED |
| 10002614 | 10001719 | 1.61 | 54.6 | Neo-adjuvant (N) | 2016-05-06 | 2016-05-23 | ECX | N | N | 10440004 | ECX |
| 10002615 | 10001720 | null | 78 | Curative (C) | null | 2015-05-25 | ECX | N | N | 10440005 | ECX |
| 10002616 | 10001721 | 0 | 68 | Neo-adjuvant (N) | 2014-06-08 | 2014-06-08 | Carboplatin + Vinorelbine Oral | 02 | N | 10440052 | CARBOPLATIN + VINORELBINE |
| 10002617 | 10001722 | 1.37 | 66.2 | Palliative (P) | 2019-07-19 | 2019-07-30 | Enzalutamide | N | N | 10440105 | ENZALUTAMIDE |
| 10002618 | 10001722 | 1.76 | 88.1 | Palliative (P) | 2017-10-21 | 2017-11-02 | Cisplatin + Pemetrexed | 02 | Y | 10440105 | CISPLATIN + PEMETREXED |
| 10002619 | 10001723 | 1.67 | 76 | Palliative (P) | 2017-01-23 | 2017-01-23 | Rituximab | 02 | N | 10440160 | RITUXIMAB |
| 10002620 | 10001724 | 1.82 | 69.65 | null | 2015-04-09 | 2015-04-09 | CVP R | 02 | N | 10440166 | CVP R |
| 10002621 | 10001725 | 0 | 67.4 | Adjuvant (A) | 2018-12-08 | 2018-12-27 | Cisplatin + Vinorelbine (PO) | N | N | 10440193 | CISPLATIN + VINORELBINE |
| 10002622 | 10006235 | 0 | 67.8 | Palliative (P) | 2015-11-10 | 2015-11-12 | Hydroxycarbamide | N | N | 10440257 | HYDROXYCARBAMIDE |
| 10002623 | 10006235 | null | 74.5 | Adjuvant (A) | 2015-10-28 | 2015-11-18 | Cisplatin + Vinorelbine (IV) | 02 | N | 10440257 | CISPLATIN + VINORELBINE |
| 10002624 | 10001726 | null | 99.9 | Curative (C) | 2018-02-07 | 2018-02-09 | EOX | N | N | 10440296 | EOX |
| 10002625 | 10006236 | 1.67 | null | Palliative (P) | 2016-09-13 | 2016-09-13 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10440316 | GEMCITABINE |
| 10002626 | 10006236 | 1.69 | 62.2 | Palliative (P) | 2017-03-14 | 2017-04-14 | ECX | 2 | N | 10440316 | ECX |
| 10002627 | 10006236 | 0 | 69.9 | Curative (C) | 2018-01-10 | 2018-01-10 | Hydroxycarbamide | 02 | N | 10440316 | HYDROXYCARBAMIDE |
| 10002628 | 10001727 | 0 | 62.2 | Curative (C) | 2015-10-02 | 2015-10-10 | Cisplatin + Vinorelbine (IV) | N | N | 10440415 | CISPLATIN + VINORELBINE |
| 10002629 | 10001727 | 1.82 | 103 | Palliative (P) | 2014-11-14 | 2014-11-16 | PEMBROLIZUMAB | N | N | 10440415 | PEMBROLIZUMAB |
| 10002630 | 10001727 | 1.48 | 63.5 | Adjuvant (A) | 2017-05-20 | 2017-05-26 | Carboplatin + Vinorelbine Oral | N | N | 10440415 | CARBOPLATIN + VINORELBINE |
| 10002631 | 10001728 | 1.73 | 89.5 | null | 2016-07-17 | 2016-08-07 | Cisplatin + Pemetrexed | 02 | N | 10440490 | CISPLATIN + PEMETREXED |
| 10002632 | 10006238 | 1.8 | null | Palliative (P) | 2015-09-13 | 2015-09-25 | Enzalutamide | 2 | N | 10440524 | ENZALUTAMIDE |
| 10002633 | 10006238 | 1.71 | 66.9 | null | 2015-04-29 | 2015-04-29 | Hydroxycarbamide | N | N | 10440524 | HYDROXYCARBAMIDE |
| 10002634 | 10001729 | 1.8 | 96 | Palliative (P) | 2015-06-26 | 2015-06-26 | PEMBROLIZUMAB | N | N | 10440576 | PEMBROLIZUMAB |
| 10002635 | 10006239 | 1.76 | 86.4 | Palliative (P) | 2016-08-12 | 2016-08-25 | Cisplatin + Pemetrexed | N | N | 10440599 | CISPLATIN + PEMETREXED |
| 10002636 | 10001730 | 1.76 | 74.4 | Palliative (P) | 2017-07-24 | 2017-07-24 | Rituximab | N | N | 10440602 | RITUXIMAB |
| 10002637 | 10001731 | null | 96 | Palliative (P) | 2016-09-08 | 2016-09-16 | PEMBROLIZUMAB | 2 | N | 10440616 | PEMBROLIZUMAB |
| 10002638 | 10001732 | 1.77 | 75.3 | Palliative (P) | 2013-09-19 | 2013-10-11 | PEMBROLIZUMAB | 02 | N | 10440647 | PEMBROLIZUMAB |
| 10002639 | 10001733 | 1.78 | 59.1 | Palliative (P) | 2014-11-01 | 2014-11-02 | Cisplatin + Pemetrexed | 02 | N | 10440659 | CISPLATIN + PEMETREXED |
| 10002640 | 10006240 | 1.73 | 70.9 | Palliative (P) | 2018-09-05 | 2018-09-05 | Trial Unspecified | Y | N | 10440700 | TRIAL |
| 10002641 | 10001734 | 1.81 | null | null | 2018-01-04 | 2018-01-12 | ECX | 02 | N | 10440735 | ECX |
| 10002642 | 10001735 | 0 | 90.9 | Neo-adjuvant (N) | 2017-05-14 | 2017-05-15 | Cisplatin + Vinorelbine (IV) | N | N | 10440741 | CISPLATIN + VINORELBINE |
| 10002643 | 10001736 | null | 93.4 | Palliative (P) | 2018-01-11 | 2018-01-24 | Cisplatin + Pemetrexed | N | null | 10440812 | CISPLATIN + PEMETREXED |
| 10002644 | 10001737 | null | null | Palliative (P) | 2017-04-03 | 2017-04-09 | PEMBROLIZUMAB | N | N | 10440843 | PEMBROLIZUMAB |
| 10002645 | 10001738 | 1.66 | 86.4 | Adjuvant (A) | 2015-09-22 | 2015-09-23 | Cisplatin + Vinorelbine (PO) | 2 | N | 10440916 | CISPLATIN + VINORELBINE |
| 10002646 | 10001738 | 1.65 | 69.4 | Palliative (P) | 2017-01-03 | 2017-01-13 | Enzalutamide | 99 | N | 10440916 | ENZALUTAMIDE |
| 10002647 | 10001738 | 1.65 | 69.7 | Disease modification (D) | 2018-05-27 | 2018-05-27 | Hydroxycarbamide | N | null | 10440916 | HYDROXYCARBAMIDE |
| 10002648 | 10001739 | 1.71 | null | Palliative (P) | 2017-12-23 | 2018-01-21 | Enzalutamide | N | N | 10440980 | ENZALUTAMIDE |
| 10002649 | 10001740 | 1.69 | 94.3 | Disease modification (D) | null | 2013-05-13 | Hydroxycarbamide | N | N | 10440986 | HYDROXYCARBAMIDE |
| 10002650 | 10001741 | 1.76 | 84.1 | Palliative (P) | 2014-02-16 | 2014-03-02 | EOX | 2 | N | 10440998 | EOX |
| 10002651 | 10001741 | 1.66 | 68.1 | Palliative (P) | 2018-09-26 | 2018-10-12 | CISPLATIN + VINORELBINE | 02 | N | 10440998 | CISPLATIN + VINORELBINE |
| 10002652 | 10001741 | 1.63 | 49.3 | Adjuvant (A) | 2014-10-20 | 2014-11-05 | Cisplatin + Vinorelbine (IV) | 02 | N | 10440998 | CISPLATIN + VINORELBINE |
| 10002653 | 10001742 | 1.58 | 56.2 | Disease modification (D) | 2016-11-18 | 2016-11-19 | Hydroxycarbamide | N | N | 10441146 | HYDROXYCARBAMIDE |
| 10002654 | 10001742 | 1.73 | 0 | Adjuvant (A) | null | 2018-02-16 | CISPLATIN + VINORELBINE | 02 | N | 10441146 | CISPLATIN + VINORELBINE |